Now showing items 1-10 of 4967
Comparison of low-density lipoprotein obtained from the Friedewald formula and new formulae in a heterogeneous population.
Introduction: Although the levels of low-density lipoprotein (LDL-C) should ideally be determined by beta quantification or enzymatic methods, there are limitations in developing countries. The goal of this study is to ...
Metodologias para determinação da lipoproteína de baixa densidade oxidada (LDL-ox) como marcador de risco cardiovascular
(Universidade Federal de Santa MariaCentro de Ciências da Saúde, 2005)
Currently, the inflammatory disorders are believe to strongly correlate with the condition of oxidative stress. Amongst them, one of the most studied is atherosclerosis. Atherosclerosis is a disease of great world-wide ...
Increased electronegative LDL and decreased antibodies against electronegative LDL levels correlate with inflammatory markers and adhesion molecules in hemodialysed patients
(ELSEVIER SCIENCE BV, 2011)
Background: Chronic Kidney Disease (CKD) patients present high levels of electronegative LDL (LDL) that can modulate the expression of molecules involved in inflammation and it is closely linked to atherosclerosis. We ...
Electronegative Low-Density Lipoprotein is Associated with Dense Low-Density Lipoprotein in Subjects with Different Levels of Cardiovascular Risk
(SPRINGER HEIDELBERG, 2010)
Dyslipidemias and physicochemical changes in low-density lipoprotein (LDL) are very important factors for the development of coronary artery disease (CAD). However, pathophysiological properties of electronegative low-density ...
Association of Postprandial Hyperglycemia with in Vitro LDL Oxidation in Non-Smoking Patients with Type 1 Diabetes - a Cross-Sectional Study
(The Society for Biomedical, 2019)
Oxidized low-density lipoproteins and their antibodies: Relationships with the reverse cholesterol transport and carotid atherosclerosis in adults without cardiovascular diseases
(ELSEVIER SCIENCE BVAMSTERDAM, 2012)
Background: Metabolic predictors and the atherogenicity of oxidized LDL (oxLDL) and the specific antibodies against oxLDL (oxLDL Ab) are unclear and controversial. Methods: In 107 adults without atherosclerotic manifestations, ...